Skip to main content
. 2023 Dec 30;16(1):196. doi: 10.3390/cancers16010196

Figure 1.

Figure 1

(left): Gastric adenocarcinoma, Hematoxylin and eosin (H+E) × 200, (right): Gastric adenocarcinoma, PD-L1 immunostaining (DAKO), DAB × 200.